| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,477,000 | 2,433,000 | 2,405,000 | 2,485,000 | | Cost of Revenue | 1,283,000 | 1,935,000 | 1,743,000 | 1,900,000 | | | Gross Profit | 194,000 | 498,000 | 662,000 | 585,000 | | | Operating Expenses | | Research Development | 110,000 | 120,000 | 99,000 | 142,000 | | Selling General and Administrative | 311,000 | 403,000 | 360,000 | 435,000 | | Non Recurring | 109,000 | 880,000 | 56,000 | (20,000) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (336,000) | (905,000) | 147,000 | 28,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (15,000) | 17,000 | 8,000 | (15,000) | | Earnings Before Interest And Taxes | (351,000) | (888,000) | 155,000 | 13,000 | | Interest Expense | 25,000 | 28,000 | 26,000 | 26,000 | | Income Before Tax | (376,000) | (916,000) | 129,000 | (13,000) | | Income Tax Expense | (16,000) | (2,000) | 28,000 | (213,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (360,000) | (914,000) | 101,000 | 200,000 | | | Non-recurring Events | | Discontinued Operations | 7,000 | (4,000) | (5,000) | 295,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (353,000) | (918,000) | 96,000 | 495,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($353,000) | ($918,000) | $96,000 | $495,000 |
|
3.07% Nasdaq 
Income Statement
